Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs have been updated today, June 1, 2021:
Effective July 1, 2021:
- Androgens and Anabolic Steroids
- Methotrexate Injectable
- Multiple Sclerosis
- Opioid ER
- Opioid IR Duration Limit
- Self-Administered Oncology
- VMAT2 Inhibitors
- HCPA CGRP
- Biologic Immunomodulators
- Lupus (Previously Benlysta)
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.